Table 1. Baseline data for control subjects and patients with CHF.
| Controls | CHF Patients | p-Value | |
| Number (female) | 20 (8) | 75 (16) | 0.09 |
| NYHA class | 2.5±0.7 | ||
| Aetiology (ischemic/non-ischemic, %) | 65/35 | ||
| LVEF (%) | 31.9±11.1 | ||
| Age (yr) | 63.3±10.1 | 67.8±10.7 | 0.09 |
| BMI (kg/m2) | 26.4±3.0 | 28.9±5.4 | 0.26 |
| Hemoglobin (g/dL) | 14.5±1.1 | 13.5±1.7 | 0.02 |
| Sodium (mmol/L) | 139±2 | 137±4 | 0.01 |
| Potassium (mmol/L) | 4.3±0.3 | 4.3±0.5 | 0.4 |
| Creatinine (µmol/L) | 83±15 | 124±44 | <0.0001 |
| Alkaline phosphatase (U/L) | 66±17 | 76±33 | 0.18 |
| Aspartate transaminase (U/L) | 28±16 | 23±10 | 0.18 |
| Gamma glutamyl transpeptidase (U/L) | 34±26 | 55±48 | 0.03 |
| Uric Acid (µmol/L) | 321±79 | 456±130 | <0.0001 |
| Cholesterol (mmol/L) | 6.0±0.7 | 4.7±1.2 | <0.0001 |
| High density lipoprotein (mmol/L) | 1.5±0.4 | 1.1±0.3 | 0.0003 |